Femasys Stock Forecast, Price & News

Femasys (NASDAQ:FEMY) Frequently Asked Questions

Is Femasys a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Femasys in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Femasys stock.
View analyst ratings for Femasys or view top-rated stocks.

What stocks does MarketBeat like better than Femasys?

Wall Street analysts have given Femasys a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Femasys wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Femasys?

Femasys saw a increase in short interest in September. As of September 30th, there was short interest totaling 18,900 shares, an increase of 293.8% from the September 15th total of 4,800 shares. Based on an average trading volume of 77,400 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.3% of the shares of the stock are sold short.
View Femasys' Short Interest.

When is Femasys' next earnings date?

Femasys is scheduled to release its next quarterly earnings announcement on Wednesday, November 10th 2021.
View our earnings forecast for Femasys.

How were Femasys' earnings last quarter?

Femasys Inc. (NASDAQ:FEMY) posted its quarterly earnings data on Wednesday, August, 11th. The company reported ($0.52) earnings per share for the quarter, missing the consensus estimate of ($0.25) by $0.27. The company had revenue of $0.33 million for the quarter.
View Femasys' earnings history.

What price target have analysts set for FEMY?

2 brokers have issued twelve-month target prices for Femasys' shares. Their forecasts range from $8.45 to $25.00. On average, they anticipate Femasys' share price to reach $16.73 in the next twelve months. This suggests a possible upside of 139.3% from the stock's current price.
View analysts' price targets for Femasys or view top-rated stocks among Wall Street analysts.

Who are Femasys' key executives?

Femasys' management team includes the following people:

• Ms. Kathy Lee-Sepsick, Founder, Chairman, CEO & Pres (Age 54, Pay $306.54k)
• Mr. Daniel Scott Currie, SVP of Operations & Sec. (Age 57, Pay $225.63k)
• Mr. Gary Thompson, CFO & VP of Fin. & Admin. (Age 64)
• Ms. Mary An Merchant J.D., Ph.D., VP of Counsel & Intellectual Property
• Mr. Steven P. Damon, VP of Bus. Devel. (Age 65)
• Mr. Todd A. Creech, Chief Financial Advisor (Age 53)
• Dr. Jeffrey Marcus M.D., M.S., Chief Medical Advisor

Who are some of Femasys' key competitors?

Some companies that are related to Femasys include Utah Medical Products (UTMD), Retractable Technologies (RVP), CVRx (CVRX), The Westaim (WEDXF), Profound Medical (PROF), Acutus Medical (AFIB), iCAD (ICAD), InfuSystem (INFU), Beyond Air (XAIR), DarioHealth (DRIO), Cytosorbents (CTSO), Apollo Endosurgery (APEN), Co-Diagnostics (CODX), TELA Bio (TELA) and Liquidia (LQDA).
View all of FEMY's competitors.

When did Femasys IPO?

(FEMY) raised $35 million in an initial public offering on Friday, June 18th 2021. The company issued 2,700,000 shares at $12.00-$14.00 per share. Chardan and JonesTrading acted as the underwriters for the IPO.

What is Femasys' stock symbol?

Femasys trades on the NASDAQ under the ticker symbol "FEMY."

When does Femasys' lock-up period expire?

Femasys' lock-up period expires on Wednesday, December 15th. Femasys had issued 2,650,000 shares in its IPO on June 18th. The total size of the offering was $34,450,000 based on an initial share price of $13.00. After the end of Femasys' lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

Who are Femasys' major shareholders?

Femasys' stock is owned by a number of retail and institutional investors. Top institutional investors include Clear Creek Financial Management LLC (0.20%).
View institutional ownership trends for Femasys.

Which institutional investors are buying Femasys stock?

FEMY stock was purchased by a variety of institutional investors in the last quarter, including Clear Creek Financial Management LLC.
View insider buying and selling activity for Femasys or or view top insider-buying stocks.

How do I buy shares of Femasys?

Shares of FEMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Femasys' stock price today?

One share of FEMY stock can currently be purchased for approximately $6.99.

How much money does Femasys make?

Femasys has a market capitalization of $82.48 million.

How many employees does Femasys have?

Femasys employs 25 workers across the globe.

What is Femasys' official website?

The official website for Femasys is www.femasys.com.

How can I contact Femasys?

The company can be reached via phone at 770-500-3910 or via email at [email protected].